济民健康：预计2025年亏损2.1亿元-2.5亿元

Core Viewpoint - The company Jimin Health (603222) has announced a forecast for a net loss of 210 million to 250 million yuan for the year 2025, compared to a loss of 59.71 million yuan in the previous year [4] Financial Performance - The expected net profit loss for 2025 is between 210 million and 250 million yuan, with a non-recurring net profit loss estimated at 205 million to 245 million yuan, compared to a loss of 58.69 million yuan in the previous year [4] - The company's price-to-book ratio (LF) is approximately 3.55 times, and the price-to-sales ratio (TTM) is about 7.78 times based on the latest closing price [4] Business Impact Factors - The company's revenue has declined further due to factors such as U.S. tariff policies and the "He Qinghong stamp forgery incident," leading to increased losses [15] - The company has made provisions for inventory impairment of approximately 37 million yuan for pre-filled catheter flushing devices and safety syringes [15] - Losses related to the "He Qinghong and others forging company seals" case have been confirmed at around 38 million yuan [15] - The performance of Ezhou Second Hospital has declined compared to the previous year, prompting the company to make a goodwill impairment provision of approximately 20 million yuan [15]